Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02452008 |
|---|---|
| Brief Title: | Study of TGF-β Receptor Inhibitor Galunisertib (LY2157299) and Enzalutamide in Metastatic Castration-resistant Prostate Cancer |
| First Submitted : | May 20, 2015 |
| First Submitted that Met QC Criteria : | May 21, 2015 |
| First Posted : | May 22, 2015 (Estimate) |
| Last Update Submitted that Met QC Criteria : | June 1, 2022 |
| Last Update Posted : | June 3, 2022 |